AliveCor
The investigation compared tests from 204 STEMI patients presenting in five different settings.
The not-yet-FDA-cleared device uses three electrodes to create a more detailed reading than existing consumer devices.
The announcement has drawn questions about novelty and claims of coziness with the FDA.
The KardiaK Software Platform could be used with mobile ECG devices to identify potential cases of kidney disease.